Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
The Food and Drug Administration (FDA) has indicated a proactive stance toward establishing a regulatory framework for Cannabidiol (CBD) while continuing to monitor kratom closely.
Kimberlee Trzeciak, FDA Deputy Commissioner for Policy, Legislation and International Affairs, announced the agency’s intent to prioritize CBD regulations in the coming year.
The FDA’s current position suggests that CBD products might not meet existing safety standards for foods and dietary supplements. The agency is exploring regulatory tools to ensure consumer clarity on product contents and safety.
New Hampshire: Legislative Divide on Marijuana Legalization
In New Hampshire, a significant legislative debate is underway regarding the approach to marijuana legalization. Marijuana Moment reported …